Alterity Therapeutics Announces Option Cessation
Company Announcements

Alterity Therapeutics Announces Option Cessation

Alterity Therapeutics Ltd. (AU:ATH) has released an update.

Alterity Therapeutics Limited has announced the cessation of 5 million options due to the non-fulfillment of conditional rights. These options, identified by the code ATHAAE and originally set to expire on November 29, 2026, officially ceased on May 7, 2024. This move is significant for investors tracking the company’s capital structure and stock performance.

For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.

Looking for more investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!